Search Results
Dec 18, 2025, 10:25 ET Haier Malaysia Gelar 7th Global Fans Festival dengan "Pop-Up Experience" yang Menarik di Pavilion Bukit Jalil
pertama yang dapat mencoba produk-produk terbaru Haier, seperti Space Fit Refrigerator, L+ AI Heat-pump Washer-Dryer, UV Cool Color Air Conditioner, M80 QD-Mini LED TV, serta menyaksikan sesi perkenalan produk mesin cuci tiga-drum yang segera diluncurkan Haier.
More news about: Haier Group
Dec 18, 2025, 01:51 ET Haier Malaysia chào đón Lễ hội người hâm mộ toàn cầu lần thứ 7 với trải nghiệm pop-up nhập vai tại Pavilion Bukit Jalil
Malaysia là một trong những thị trường đầu tiên trải nghiệm tủ lạnh Space Fit, máy giặt – sấy bơm nhiệt AI L+, máy điều hòa không khí UV Cool Color, TV QD-Mini LED M80, và được trải nghiệm trước máy giặt ba lồng sắp ra mắt.
More news about: Haier Group
Dec 18, 2025, 00:29 ET 하이얼 말레이시아, 파빌리온 부킷 잘릴의 몰입형 팝업 공간에서 제7회 글로벌 팬 페스티벌 개최
하이얼은 이번 페스티벌에서 붙박이 냉장고(Space Fit Refrigerator), L+ AI 히트펌프 방식 세탁건조기(L+ the AI Heat-pump Washer-Dryer), UV 쿨 컬러 에어컨(UV Cool Color Air Conditioner), M80 QD-Mini LED TV 등 혁신적인 신제품을 말레이시아 소비자에게 처음으로 선보이고, 이와 함께 차세대 트리플 드럼 세탁기도 미리 공개했다.
More news about: Haier Group
Dec 17, 2025, 10:57 ET Haier Malaysia Welcomes the 7th Global Fans Festival with Immersive Pop-Up Experience at Pavilion Bukit Jalil
Malaysian consumers are among the first to experience the Space Fit Refrigerator, L+ the AI Heat-pump Washer-Dryer, the UV Cool Color Air Conditioner, M80 QD-Mini LED TV, and a preview of the upcoming triple-drum washing machine.
More news about: Haier Group
Dec 11, 2025, 20:18 ET Philips Evnia創新突破性 電競護眼顯示屏問世 獲TÜV認證並與《Sonic Racing: CrossWorlds》
CrossWorlds 2025 獨家合作限定優惠 (數量有限，送完即止) :【指定型號Evnia電競顯示屏】於活動期間，選購指定：1) 電競界「護眼神盾」NATURE EYE CARE 型號Evnia 27M2N5501UK；2) QD-OLED型號Evnia 27M2N6500L, 27M2N6500P, 27M2N8500, 27M2N8800, 32M2N8800, 32M2N8900, 49M2N8900；3) DUAL Hz型號Evnia 27M2N3800A, 32M2N5800，即可獲贈Sonic
More news about: 飛利浦顯示屏/Philips Evnia
Dec 11, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
Phase 2 RP trial to Q1 2026," describing the shift as "provid[ing] us with an opportunity to introduce dose-ranging studies with our new once-daily or QD formulation in the current Phase 2 study while also expanding into Canada, EU and the UK, a strategy we feel will accelerate Phase 3 timelines." On
More news about: Pomerantz LLP
Dec 11, 2025, 04:00 ET Qudian Inc. Announces Name and Ticker Change
XIAMEN, China, Dec. 11, 2025 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company in China, today announced the change of its name to "High Templar Tech Limited" and its ticker symbol to "HTT".
More news about: Qudian Inc.
Dec 10, 2025, 10:11 ET Menarini Group、2025年サンアントニオ乳がんシンポジウムにてエラセストラント（ORSERDU®）併用療法の第2相データをER+、HER2-転移性乳がん（mBC）患者を対象に発表
エラセストラント 345mg QD+ エベロリムス 7.5mg QD(n=50)
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 09, 2025, 11:38 ET El Grupo Menarini presenta datos de la combinación de fase 2 de Elacestrant (ORSERDU®) en cáncer de mama
mg QD + Everolimus 7,5 mg QD (n=50) Elacestrant 345 mg QD
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 09, 2025, 05:00 ET Dizal Showcases its Strong Hematology Pipeline with New Data from Golidocitinib and Birelentinib at ASH 2025
this ASH Annual Meeting demonstrated potent anti-tumor efficacy with a manageable safety profile in heavily pre-treated CLL/SLL patients.At 50 mg QD (RP3D), birelentinib achieved an ORR of 84.2%. Tumor responses were observed irrespective of prior BTK inhibitor, BCL-2 inhibitor or BTK degrader treatment,
More news about: Dizal Pharmaceutical
Dec 08, 2025, 15:17 ET Le groupe Menarini présente les données de la phase 2 sur l'association d'Elacestrant (ORSERDU®) chez des patientes atteintes d'un cancer du sein métastatique (mBC) ER+, HER2- lors du 2025 San Antonio Breast Cancer Symposium
Elacestrant 345 mg QD+ Everolimus 7,5 mg QD(n=50)
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 08, 2025, 14:47 ET Menarini Group präsentiert Daten zur Phase-2-Kombination von Elacestrant (ORSERDU®) bei Patientinnen mit ER+, HER2- metastasiertem Brustkrebs (mBC) auf dem San Antonio Breast Cancer Symposium 2025
Elacestrant 345 mg QD+ Everolimus 7,5mg QD(n=50)
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 08, 2025, 13:41 ET Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
Elacestrant 345 mg QD+ Everolimus 7.5mg QD(n=50)
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 08, 2025, 13:30 ET Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
Elacestrant 345 mg QD+ Everolimus 7.5mg QD(n=50)
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 08, 2025, 08:30 ET Spinogenix Reports Evidence of Rapid, Sustained Cognitive Improvement in Alzheimer's Patients from Phase 2a Trial of TAZBENTETOL (formerly SPG302)
measures of AD-related brain activity. Participants had the option to remain on treatment past the open label period for an additional 52 weeks at 300mg QD.Topline results for the 300mg dose from the completed trial, presented at the Clinical Trials on Alzheimer's Disease (CTAD) conference on December
More news about: Spinogenix
Dec 08, 2025, 07:47 ET TCL Unveils 'Wishes for Greatness' Winter Wonderland with Lighting Ceremony for the Tree of the Games in Milan
heartfelt wish, such as the 'Harmony Theatre' representing Europe decorated like a quintessential opera house. With surround sound created by the X11K QD-Mini LED TV and TCL Z100 Wireless Free Sound Speaker, audiences can enjoy an immersive view of figure skating performances from the front row and take
More news about: TCL
Dec 07, 2025, 09:30 ET Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
(TD) patients (≥16 weeks follow up) at dose levels of at least 500 mg QD and higher, 6/18 (33%) patients achieved durable red blood cell transfusion independence (RBC-TI) of >8 weeks [500 mg QD (1/3), 750 mg QD (2/5), 500/250 mg QD (1/5), 500 mg BID (2/5)]. Duration of RBC-TI was >16 weeks in 4 patients
More news about: Rigel Pharmaceuticals, Inc.
Dec 01, 2025, 14:18 ET Quantum Computing-As-A-Service (QCaaS) Market to Reach USD 18,598.33 million by 2032 at 33.88% CAGR - Credence Research
to your industry needsQuantum Dots Display (QD Display) Market - https://www.credenceresearch.com/report/quantum-dots-qd-marketQuantum Computing Market -
More news about: Credence Research Inc.
Nov 24, 2025, 13:51 ET TCL Launches Massive Black Friday Deals Across Home Theater and Mobile Devices
the premium television category:TCL QM6K QD-Mini LED TV: Up to 64% off this brilliant Mini LED display with vibrant QLED color for stunning clarity and contrast at an unbeatable value.TCL QM7K QD-Mini LED TV: Save up to $10,000 on this model, featuring stunning
More news about: TCL North America
Nov 24, 2025, 05:00 ET Qudian Inc. Reports Third Quarter 2025 Unaudited Financial Results
XIAMEN, China, Nov. 24, 2025 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company in China, today announced its unaudited financial results for the quarter ended September 30, 2025. Third
More news about: Qudian Inc.
Nov 17, 2025, 06:30 ET Nuvalent Announces Positive Topline Pivotal Data from ALKOVE-1 Clinical Trial of Neladalkib for TKI Pre-treated Patients with Advanced ALK-positive NSCLC
trial for patients with advanced ALK-positive NSCLC and other solid tumors. The recommended Phase 2 dose (RP2D) for neladalkib of 150 mg once daily (QD) was determined during the Phase 1 dose-escalation portion of the trial. The global, single-arm, multi-cohort, open-label Phase 2 portion is designed
More news about: Nuvalent, Inc.
Nov 13, 2025, 14:56 ET La nueva generación de monitores Odyssey llega a México con la Copa Odyssey
con una frecuencia de actualización de 500 Hz, lo que se traduce en precisión y velocidad de vanguardia para ganar. Se complementa con la tecnología QD-OLED, que genera escenas vibrantes, colores intensos y resolución QHD, sumergiéndote por completo en cada partida. Para jugar sin
More news about: Samsung Mexico
Nov 12, 2025, 09:01 ET Stäubli Expands U.S. Manufacturing and Reinforces Leadership in Liquid Cooling
its involvement with the Mini-QD and leadership in the UQD v2 standardization,
More news about: Staubli
Nov 12, 2025, 05:00 ET Qudian Inc. Announces Board Approval of Changes to Company Name and Ticker Symbol, as well as Calling of Extraordinary General Meeting
XIAMEN, China, Nov. 12, 2025 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company in China, today announced that the Company's board of directors (the "Board") resolved to change the Company's
More news about: Qudian Inc.
Nov 11, 2025, 01:00 ET SUN GROUP AND CIRQUE DU SOLEIL: TWO WORLD LEADERS SHAPING THE FUTURE OF VIETNAM'S LIVE ENTERTAINEMENT TOGETHER
two major brands, but also an important step in realizing our aspiration to elevate Vietnam's cultural industry, in alignment with Decision No. 1755/QĐ-TTg of the Prime Minister approving the Strategy for the Development of Vietnam's Cultural Industries to 2020, with a vision to 2030. With the combination
More news about: Cirque du Soleil